A series of “turn-on” response mechanism compounds (F1-F4) to TYR have been designed and synthesized. Based on tyrosinase-triggered oxidative reaction and urea hydrolysis reaction, F2 have excellent sensitivity and selectivity toward tyrosinase in vitro. F2 was successfully used to imaging living melanoma cells as a result of the conversion of F2 to F0 by TYR catalysis.